beta-cyclocitral has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsayed, AMM; Han, H; Liu, Z; Shen, A; Wang, K; Wang, Y; Yan, Q; Ye, Y; Zhang, J; Zheng, X | 1 |
1 other study(ies) available for beta-cyclocitral and Liver Neoplasms
| Article | Year |
|---|---|
Discovery of β-cyclocitral-derived mono-carbonyl curcumin analogs as anti-hepatocellular carcinoma agents via suppression of MAPK signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Curcumin; Hep G2 Cells; Humans; Liver Neoplasms; Signal Transduction | 2023 |